Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.48 |
| ▸ | NPY4R | P50391 | 4/20 | 0.48 |
| ▸ | NPY1R | P25929 | 3/20 | 0.48 |
| ▸ | NPY2R | P49146 | 3/20 | 0.48 |
| ▸ | NMT2 | O60551 | 1/20 | 0.46 |
| ▸ | NMT1 | P30419 | 1/20 | 0.46 |
| ▸ | GSR | P00390 | 1/20 | 0.45 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.43 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.43 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.41 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.41 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30298866 | 0.99 | NMT2 (0.47) | MMENPY4RNPY1RNPY2RNMT2 | |
| SCHEMBL31573967 | 0.95 | NMT2 (0.48) | MMENPY4RNPY1RNPY2RNMT2 | |
| SCHEMBL29740735 | 0.93 | NPY1R (0.50) | NPY4RNPY1RNPY2RGSRCPB2 | |
| SCHEMBL30397735 | 0.93 | NPY1R (0.50) | NPY4RNPY1RNPY2RGSRCPB2 | |
| SCHEMBL30478747 | 0.92 | NMT2 (0.49) | MMENPY4RNPY1RNPY2RNMT2 | |
| SCHEMBL29630493 | 0.92 | NMT1 (0.52) | MMENPY4RNPY1RNPY2RNMT2 | |
| SCHEMBL29404079 | 0.92 | NPY4R (0.52) | NPY4RNPY1RNPY2RGSRCPB2 | |
| SCHEMBL31343172 | 0.92 | NPY4R (0.52) | NPY4RNPY1RNPY2RGSRCPB2 | |
| SCHEMBL29630455 | 0.92 | NPY4R (0.47) | MMENPY4RNPY1RNPY2RNMT2 | |
| SCHEMBL30484834 | 0.92 | NPY4R (0.47) | MMENPY4RNPY1RNPY2RNMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119192374-A | CD138 antibody molecules and uses thereof | 威特拉公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118103059-A | Self-assembled nanoparticles based on amphiphilic peptides | 巴林萨斯生物疗法北美公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117843642-A | Difunctional compound and application thereof | 麦科萨药业(苏州)有限公司 | 2024-04-09 | — | — | CN | claimed |
| EP-4294431-A1 | SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES | Vaccitech North America, Inc. (US) | 2023-12-27 | — | — | EP | claimed |
| WO-2022177993-A1 | SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES | VACCITECH NORTH AMERICA, INC. (US) | 2022-08-25 | — | — | WO | claimed |
| US-20220204592-A1 | HA BINDING AGENTS | Visterra, Inc. | 2022-06-30 | — | — | US | claimed |
| CN-117843642-B | Difunctional compound and application thereof | 麦科萨药业(苏州)有限公司 | 2026-04-10 | — | — | CN | disclosed |
| US-12303545-B2 | Polypeptide with anti-Mycobacterium tuberculosis activity, and preparation method and use thereof | Agricultural University of Nanjing (CN) | 2025-05-20 | — | — | US | disclosed |
| US-20250127887-A1 | Self-Assembling Nanoparticles Based On Amphiphilic Peptides | BARINTHUS BIOTHERAPEUTICS NORTH AMERICA, INC. (US) | 2025-04-24 | — | — | US | disclosed |
| US-12202885-B2 | Formulations of antibody molecules to influenza virus | Visterra, Inc. (US) | 2025-01-21 | — | — | US | disclosed |
| CN-119192374-A | CD138 antibody molecules and uses thereof | 威特拉公司 | 2024-12-27 | — | — | CN | disclosed |
| US-20240415925-A1 | POLYPEPTIDE WITH ANTI-MYCOBACTERIUM TUBERCULOSIS ACTIVITY, AND PREPARATION METHOD AND USE THEREOF | Agricultural University of Nanjing (CN) | 2024-12-19 | — | — | US | disclosed |
| WO-2024255185-A1 | POLYPEPTIDE HAVING ANTI-MYCOBACTERIUM TUBERCULOSIS ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF | 南京农业大学 | 2024-12-19 | — | — | WO | disclosed |
| CN-116514925-A | Mycobacterium tuberculosis-resistant polypeptide, preparation method and application thereof | 南京农业大学 | 2023-08-01 | — | — | CN | disclosed |
| US-20230033133-A1 | VACCINE CONJUGATES | ULTIMOVACS AB (SE) | 2023-02-02 | — | — | US | disclosed |
| WO-2023006083-A1 | NEUROPROTECTIVE POLYPEPTIDE COMPOUND AND APPLICATION THEREOF | 英纳氏(珠海)药业有限公司 | 2023-02-02 | — | — | WO | disclosed |
| WO-2022177993-A1 | SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES | VACCITECH NORTH AMERICA, INC. (US) | 2022-08-25 | — | — | WO | disclosed |
| US-20220204592-A1 | HA BINDING AGENTS | Visterra, Inc. | 2022-06-30 | — | — | US | disclosed |
| EP-3946613-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLUENZA | Visterra, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| US-11230593-B2 | Compositions and methods for treating and preventing influenza | Visterra, Inc. (US) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127887-A1 | Self-Assembling Nanoparticles Based On Amphiphilic Peptides | IAPP, BRCA1, ANXA11 | MME 1318/4885NPY4R 2700/4885NPY1R 1694/4885 |
| US-20230033133-A1 | VACCINE CONJUGATES | KLK3, CD4, CD74 | MME 239/4885NPY4R 3519/4885NPY1R 3223/4885 |
| US-11230593-B2 | Compositions and methods for treating and preventing influenza | HAVCR2, FCGR3B, FCGR2A | MME 61/4885NPY4R 4595/4885NPY1R 4643/4885 |
| US-12202885-B2 | Formulations of antibody molecules to influenza virus | HAVCR2, FCGR3B, CD81 | MME 102/4885NPY4R 2938/4885NPY1R 2863/4885 |
| US-20220204592-A1 | HA BINDING AGENTS | HAVCR2, CD44, CD2BP2 | MME 38/4885NPY4R 4161/4885NPY1R 4222/4885 |
| US-12303545-B2 | Polypeptide with anti-Mycobacterium tuberculosis activity, and preparation method and use thereof | PCNA, CTDSP1, POLM | MME 695/4885NPY4R 4107/4885NPY1R 4023/4885 |
| US-20240415925-A1 | POLYPEPTIDE WITH ANTI-MYCOBACTERIUM TUBERCULOSIS ACTIVITY, AND PREPARATION METHOD AND USE THEREOF | PCNA, CTDSP1, POLM | MME 695/4885NPY4R 4107/4885NPY1R 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.